Learn More
Oesophageal cancer is one of the most aggressive cancers and is the sixth leading cause of cancer death worldwide. Approximately 70% of global oesophageal cancer cases occur in China, with oesophageal squamous cell carcinoma (ESCC) being the histopathological form in the vast majority of cases (>90%). Currently, there are limited clinical approaches for the(More)
BACKGROUND Recurrent genetic abnormalities that correlate with clinical features could be used to determine patients' prognosis, select treatments and predict responses to therapy. Esophageal squamous cell carcinoma (ESCC) contains genomic alterations of undefined clinical significance. We aimed to identify mutually exclusive mutations that are frequently(More)
In this paper, the rate of the returns is predicted using AR-MRNN and SVM and then the prediction-based portfolio selection model using SVM and the prediction-based portfolio selection model using AR-MRNN are proposed. Compared with the performance of the prediction of the AR-MRNN predictor and the SVM predictor, we found that the accuracy of the SVM is(More)
  • 1